Fredrik Lehmann
PhD, Head of Chemistry, Manufacturing & Control (C
Oncology
Oncopeptides
Sweden
Biography
Fredrik Lehmann was appointed Head of CMC in 2010. In addition to being Head of CMC for Oncopeptides, Fredrik is General Manager Recipharm OT Chemistry AB, a global Contract Development and Manufacturing Organisation (CDMO). Fredrik has previously held positions at a number of life sciences businesses including Pharmacia, Personal Chemistry and Biovitrum and has worked as an independent CMC consultant. He has also co-founded six life science companies. Fredrik holds a PhD in medicinal chemistry from Gothenburg University. Born: 1976 Holdings in Oncopeptides: 2 000 shares (Indirectly owned through OT Lehmann Holding AB) and 79 Share Options* Other current positions: Director and CEO of OncoTargeting Cancer AB and OT Pharmaceuticals AB. Board member of OT Lehmann Holding AB and Synartro AB.
Research Interest
Fredrik has previously held positions at a number of life sciences businesses including Pharmacia, Personal Chemistry and Biovitrum and has worked as an independent CMC consultant. He has also co-founded six life science companies.
